I agree that this site is using cookies. You can find further informations here.
X
Ortega-Gutierrez, Silvia
141  results:
OpenAccess-fulltext X
Search for persons X
?
1

New Pharmacological Approaches for Rare Diseases:

Ortega-Gutiérrez, Silvia
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139002/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Novel antagonist of the type 2 lysophosphatidic acid recept..:

Khiar-Fernández, Nora ; Zian, Debora ; Vázquez-Villa, Henar...
Agencia Estatal de Investigación PID2020-120267RB-I00.  , 2022
Link: https://ddd.uab.cat/reco..
 
?
3

New Trends in Aging Drug Discovery:

Benhamú, Bellinda ; Martín-Fontecha, Mar ; Vázquez-Villa, Henar..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405986/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Novel Antagonist of the Type 2 Lysophosphatidic Acid Recept..:

Khiar-Fernández, Nora ; Zian, Debora ; Vázquez-Villa, Henar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421655/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

Isoprenylcysteine Carboxylmethyltransferase-Based Therapy f..:

Marcos-Ramiro, Beatriz ; Gil-Ordóñez, Ana ; Marín-Ramos, Nagore I...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393201/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
6

Isoprenylcysteine Carboxylmethyltransferase-Based Therapy f..:

Marcos-Ramiro, Beatriz ; Gil-Ordóñez, Ana ; Marín-Ramos, Nagore I...
10.1021/acscentsci.0c01698.  , 2021
Link: https://hdl.handle.net/2..
 
?
7

A Novel Agonist of the Type 1 Lysophosphatidic Acid Recepto..:

González-Gil, Inés ; Zian, Debora ; Vázquez-Villa, Henar...
http://hdl.handle.net/10668/14777.  , 2019
Link: http://hdl.handle.net/10..
 
?
8

A novel agonist of the type 1 lysophosphatidic acid recepto..:

González-Gil, Inés ; Zian, Debora ; Vázquez-Villa, Henar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344333/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
9

Deregulation of the endocannabinoid system and therapeutic ..:

Manterola, Andrea ; Bernal-Chico, Ana ; Cipriani, Raffaela...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239900/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
10

Ligand chain length drives activation of lipid G protein-co..:

Troupiotis-Tsaïlaki, Anastassia ; Zachmann, Julian ; González-Gil, Inés...
uri/info:doi/10.1038/s41598-017-02104-5.  , 2017
Link: http://hdl.handle.net/20..
 
?
11

Ligand chain length drives activation of lipid G protein-co..:

Troupiotis-Tsaïlaki, Anastassia ; Zachmann, Julian ; González-Gil, Inés...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435731/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
12

2-Arachidonoylglycerol Reduces Proteoglycans and Enhances R..:

Feliú, Ana ; Bonilla del Río, Itziar ; Carrillo-Salinas, Francisco Javier...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596867/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
13

Chemoproteomic Approach to Explore the Target Profile of GP..:

Gamo, Ana M ; González-Vera, Juan A ; Rueda-Zubiaurre, Ainoa...
https://doi.org/10.1002/chem.201503101.  , 2016
Link: https://hdl.handle.net/2..
 
?
14

Chemoproteomic Approach to Explore the Target Profile of GP..:

Gamo, Ana M ; Gónzalez-Vera, Juan A ; Rueda-Zubiaurre, Ainoa...
SAF2013-48271.  , 2015
Link: https://hdl.handle.net/2..
 
?
15

New synthetic inhibitors of fatty acid synthase with antica..:

Turrado, Carlos ; Puig i Miquel, Teresa ; García-Cárceles, Javier...
Versió postprint del document publicat a: https://doi.org/10.1021/jm2016045.  , 2012
Link: http://hdl.handle.net/24..
 
1-15